Attached files

file filename
8-K - FORM 8-K - WALKER INNOVATION INC.wlkr20171018_8k.htm

Exhibit 99.1

 


WALKER INNOVATION ANNOUNCES THIRD QUARTER 2017 RESULTS

 

Approximately $25 Million Cash Balance, Operating Expenses Decreased by 60% from Prior-Year Period

 

Stamford, CT – October 30, 2017 – Walker Innovation Inc. (OTCQB: WLKR) (“Walker Innovation” or the “Company”), which seeks to develop and commercialize its unique portfolio of intellectual property assets through licensing and enforcement operations and is pursuing an effort to acquire one or more operating businesses, today announced third quarter 2017 results.

 

Third Quarter 2017 Highlights

 

 

As of September 30, 2017, Walker Innovation had $24.6 million in cash and no outstanding debt on its consolidated balance sheet.

 

Recorded net revenue of $0.3 million in connection with a licensing and enforcement settlement during the quarter.

 

Net loss for the third quarter of 2017 was $0.4 million, or $0.02 per share, compared to net loss of $1.1 million, or $0.05 per share, in the prior-year period.

 

Operating expenses decreased by 60% to $0.6 million for the third quarter of 2017, compared to $1.6 million for the third quarter of 2016.

 

We continue to actively explore potential acquisitions,” said Jonathan Siegel, the Company’s Chief Executive Officer. “The recent licensing and enforcement settlement and additional progress toward reducing operating expenses evidence our commitment to preserving our cash balance for future acquisitions and other potential opportunities to create shareholder value.”

 

Third Quarter 2017 Results

 

For the third quarter ended September 30, 2017, Walker Innovation reported total revenue of $0.3 million versus total revenue of $0.7 million in the prior-year period, while net revenue of $0.3 million was comparable with the prior-year period. Management expects that the timing and results of the Company’s enforcement proceedings relating to its intellectual property rights will fluctuate from period to period.

 

Total operating expenses for the third quarter 2017 were approximately $0.6 million versus $1.6 million in the prior-year period, primarily due to reduced overhead by eliminating positions and streamlining processes to conserve cash.

 

Net loss for the third quarter of 2017 was $0.4 million, compared to net loss of $1.1 million in the prior-year period. Third quarter 2017 net loss included income tax expense of $0.2 million incurred in connection with the June 2, 2017 redemption by The Upside Travel Company, LLC of 12.65 million of its shares from the Company. Net loss per common share for the third quarter of 2017 was $0.02, compared to net loss per common share of $0.05 in the prior-year period.

 

Liquidity and Capital Resources

 

As of September 30, 2017, Walker Innovation had $24.6 million in cash and no outstanding debt on its consolidated balance sheet.

 

Forward-Looking Statements

 

This press release may contain certain “forward-looking statements” that reflect the Company’s current expectations and projections about its future results, performance, prospects and opportunities. When used, the words “anticipate,” “believe,” “estimate,” “expect” and “intend” and words or phrases of similar import, as they relate to Walker Innovation, are intended to identify forward-looking statements. Such forward-looking statements include, in particular, projections about the Company’s future results, statements about its plans, strategies, business prospects, changes and trends in its business and the markets in which it operates.

 

Additionally, statements concerning future matters such as revenue levels, expense levels, and other statements regarding matters that are not historical are forward-looking statements. Management cautions that these forward-looking statements relate to future events or the Company’s future financial performance and are subject to business, economic, and other risks and uncertainties, both known and unknown, that may cause actual results, levels of activity, performance, or achievements of its business or its industry to be materially different from those expressed or implied by any forward-looking statements. Factors that could cause or contribute to such differences in results and outcomes include, but are not limited to, those discussed under the section entitled “Risk Factors” in the Company’s most recently filed Annual Report on Form 10-K and in any Risk Factors or cautionary statements contained in its Quarterly Reports on Form 10-Q or Current Reports on Form 8-K. Readers should carefully review this information as well as other risks and uncertainties described in other filings the Company makes with the Securities and Exchange Commission, or the SEC. The Company does not undertake any obligation to publicly update these forward-looking statements. As a result, investors should not place undue reliance on these forward-looking statements.

    

 

 

   

About Walker Innovation Inc. 

 

Walker Innovation (OTCQB: WLKR) owns and seeks to commercialize, license and enforce the unique portfolio of intellectual property developed by inventor and entrepreneur Jay Walker, who serves as the Company’s Executive Chairman. The Company has a history of performing innovation services that help companies improve their internal product and business development efforts. The Company’s current plan of operations includes an effort to acquire, through merger, share exchange or other transactions, one or more operating businesses, or control of such operating businesses through contractual arrangements. Mr. Walker is best known as the founder of Priceline.com and has twice been named by TIME magazine as “one of the top 50 business leaders of the digital age.” Mr. Walker currently ranks as the world’s 13th most patented living individual, based on U.S. patent issuances according to Wikipedia.  Additional information regarding the company can be found at www.walkerinnovation.com 

 

Investor Contact for Walker Innovation Inc.: 
Don Duffy/Garrett Edson, ICR 
(203) 682-8200 

 

Media Contact: 
Michael Fox, ICR 
(203) 682-8218

 

 

     

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(dollars in thousands, except per share amounts)

(Unaudited)

 

   

Three Months Ended
September
30,

   

Nine Months Ended
September
30,

 
   

2017

   

2016

   

2017

   

2016

 

Revenues:

                               

Licensing fees

  $ 300     $ 100     $ 300     $ 602  

Custom innovation – related party

    --       630       --       1,733  

Subscription Revenue

    --       --       --       75  

Total revenues

    300       730       300       2,410  
                                 

Cost of Revenue:

                               

Legal and consulting contingency fees

    --       25       --       25  

Cost of Subscription Revenue

    --       --       --       199  

Cost of custom innovation

    --       415       --       1,400  
      --       440       --       1,624  
                                 

Net revenue

    300       290       300       786  
                                 

Operating expenses:

                               

Other legal and consulting fees

    28       174       280       1,342  

Patent prosecution and maintenance fees

    6       59       75       143  

Compensation and benefits (includes non-cash stock based compensation of $24 and $461 for the three months ended September 30, 2017 and 2016, respectively)

    330       914       1,386       3,025  

Professional fees

    162       268       607       796  

General and administrative

    111       169       401       582  

Restructuring charge

    --       --       --       575  

Total operating expenses

    637       1,584       2,749       6,463  

Operating net loss

    (337

)

    (1,294

)

    (2,449

)

    (5,677

)

                                 

Other Income:

                               

Realized gain on investment

    --       --       2,189       --  

Unrealized gain on investment

    --       --       --       6,536  

Other income

    93       157       322       597  

Interest income

    17       1       28       6  

Income (loss) before income tax expenses

    (227

)

    (1,136

)

    90       1,462  
                                 

Provision for income taxes

    (219

)

    --       (256

)

    --  

Net Income (loss)

  $ (446

)

  $ (1,136

)

  $ (166

)

  $ 1,462  
                                 

Net income (loss) per common share:

                               

Basic

  $ (0.02

)

  $ (0.05

)

  $ (0.01

)

  $ 0.07  

Diluted

  $ (0.02

)

  $ (0.05

)

  $ (0.01

)

  $ 0.04  
                                 

Weighted average common shares outstanding:

                               

Basic

    20,400       20,742       20,580       20,742  

Diluted

    20,400       20,742       20,580       35,922  

 

 

 

    

CONDENSED CONSOLIDATED BALANCE SHEETS

(dollars in thousands, except share and per share amounts)

 

   

September 30, 2017

   

December 31, 2016

 
   

(Unaudited)

         

ASSETS

               

Current Assets:

               

Cash and cash equivalents

  $ 24,634     $ 10,285  

Short-term investment

    25       25  

Prepaid expenses and other current assets

    269       398  

Total current assets

    24,928       10,708  
                 

Property and equipment, net

    1       9  
                 

Other Assets:

               

Investment, at fair value

    --       14,621  

Investment, at cost

    --       250  

TOTAL ASSETS

  $ 24,929     $ 25,588  
                 

LIABILITIES AND STOCKHOLDERS' EQUITY

               

Current Liabilities:

               

Accounts payable

  $ 151     $ 214  

Accrued expenses

    90       461  

Deferred revenue

    64       316  

Total current liabilities

    305       991  
                 

TOTAL LIABILITIES

    305       991  
                 

COMMITMENTS AND CONTINGENCIES

               
                 

STOCKHOLDERS' EQUITY

               
                 

Preferred stock, $0.001 par value, 15,000,000 shares authorized

           

Series B Convertible Preferred stock, $0.001 par value, 14,999,000 shares designated, issued and outstanding, as of September 30, 2017 and December 31, 2016 respectively

    15       15  

Common stock, $0.001 par value, 100,000,000 shares authorized; 21,134,744 shares issued and 20,400,368 and 20,741,572 shares outstanding as of September 30, 2017 and December 31, 2016 respectively

    21       21  

Treasury stock, 734,376 and 393,172 shares, at cost as of September 30, 2017 and December 31, 2016, respectively

    (965

)

    (840

)

Additional paid-in capital

    47,303       46,985  

Accumulated deficit

    (21,750

)

    (21,584

)

TOTAL STOCKHOLDERS' EQUITY

    24,624       24,597  

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

  $ 24,929     $ 25,588